BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 7, 2004
View Archived Issues
Exelixis makes significant progress in expanding and advancing development pipeline during Q1
Read More
Nuvelo expands pipeline to three cardiovascular candidates
Read More
Nektar Therapeutics reports positive developments on late-stage programs
Read More
Effective wound healing by topical application of novel preclinical therapeutic peptides
Read More
Leptin accelerates wound angiogenesis in vivo
Read More
Latest phase III data on exenatide in type 2 diabetes presented at ADA
Read More
Tripep receives approval to conduct alphaHGA microdosing study
Read More
Wyeth reviews R&D pipeline
Read More
MDI-based insulin regimen is more cost-effective than CSII
Read More
Successful islet cell transplantation using the Edmonton protocol
Read More
CV Therapeutics and FDA agree on Ranexa study protocol
Read More
Positive phase III results for Aryplase in MPS VI
Read More
Solvay reviews bifeprunox development
Read More
V.I. Technologies to merge with Panacos
Read More
New phase II study of ABT-874 for MS
Read More
Iconix to provide advanced chemogenomic profiling services to AstraZeneca
Read More
Data on intratumoral injection of INGN-241 in advanced cancer patients
Read More
Trillium Therapeutics inlicenses cytokine receptor antagonist program
Read More
Enrollment completed in CONFIRM 1 study of PTK/ZK for colorectal cancer
Read More
Clofarabine NDA accepted for priority review
Read More
Strattera receives U.K. approval
Read More
LL-37 demonstrates angiogenic activity in vitro
Read More
Cannabinoid receptor partial agonist with antihyperalgesic and antiallodynic effects in vivo
Read More
SD-208 shows promise in models of pulmonary fibrosis
Read More
Losartan reduces lung injury in preclinical studies
Read More
Gilead claims new HIV integrase inhibitors
Read More
New bone resorption inhibitors targeting OCIF presented by Sankyo
Read More
Novel GAL3 antagonists and their use in depression and anxiety treatment
Read More
New hypoglycemic agents developed by Yissum and Hadasit researchers
Read More
Sumitomo patent covers novel agents for use in autoimmune diseases
Read More
New dopaminergic and serotonergic agents identified at ProteoSys
Read More
